Table 1.
Characteristics of participants at baseline according to the incidence of major adverse cardiovascular event over the 7-year follow-up
| Major cardiovascular event | |||
|---|---|---|---|
| No (N = 210) | Yes (N = 22) | p | |
| Age (years) | 50.54 ± 16.76 | 60.56 ± 13.30 | 0.007 |
| Sex men | 121 (57.6) | 17 (77.2) | 0.07 |
| BMI (kg/m2) | 24.7 ± 3.7 | 27.1 ± 6.3 | 0.09 |
| Diabetes duration (years) | 20.6 ± 12.8 | 29.6 ± 17.8 | 0.03 |
| HbA1c (mmol/ml) in 2009 (%) | 7.6 ± 1.0 | 7.5 ± 1.0 | 0.74 |
| Insulin pump | 40 (19.0) | 5 (22.7) | 0.77 |
| Smoking habits (n = 219) | 51 (25.8) | 4 (18.1) | 0.43 |
| HDL (g/l) (n = 222) | 0.64 ± 0.19 | 0.58 ± 0.17 | 0.17 |
| LDL (g/l) (n =t221) | 1.03 ± 0.29 | 1.04 ± 0.33 | 0.88 |
| Triglycerides (g/l) (n = 205) | 0.89 ± 0.63 | 1.11 ± 0.53 | 0.13 |
| Statin at baseline (n = 222) | 45 (22.5) | 13 (59.0) | 0.0002 |
| Hypertension | 87 (41.43) | 18 (81.82) | 0.0003 |
| Previous history of MACE | 13 (6.19) | 10 (45.45) | < 0.0001 |
| eGFR (mL/min) (n = 225) | |||
| ≥ 60 | 179 (88.18) | 13 (59.09) | 0.001 |
| < 60 | 24 (11.82) | 9 (40.91) | |
| Albumin excretion rate (mg/24 h) (n = 227) | |||
| < 30 | 179 (86.89) | 12 (57.14) | 0.002 |
| ≥ 30 | 27 (13.11) | 9 (42.86) | |
| SAF (AU) | 2.08 (0.54) | 2.63 (0.73) | 0.002 |
Data presented in N (%) and mean ± standard deviation
p value: COX test for qualitative variables and quantitative variables